• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1基因多态性与不孕女性子宫内膜发育不全的相关性研究

[Association of genetic polymorphism in plasminogen activator inhibitor-1 gene with endometrial hypoplasia in infertile women].

作者信息

Sun Jing-hua, Guan Li -xue, Lin Dong-ju, Dai Pei-feng, Pan Li, Mu Qian

机构信息

Department of Genetics,Weifang People's Hospital, Weifang, Shandong, 261041 People's Republic of China.

出版信息

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):462-4.

PMID:18683152
Abstract

OBJECTIVE

To investigate the relationship between the plasminogen activator inhibitor (PAI-1) polymorphisms and endometrial hypoplasia in infertile women.

METHODS

The study was conducted in 105 primary infertile patients with endometrial hypoplasia diagnosed by pathology and the thickness of endometrium by B-mode ultrasound and 85 controls who were not pregnant and had normal fertility. The -675 4G/5G polymorphism in the PAI-1 gene was detected by polymerase chain reaction-restriction fragment length polymerphim analysis.

RESULTS

The frequencies of 4G/4G genotype and 4G allele of the PAI-1 gene were higher in the patient group (48.6% and 66.2%) than in the normal controls (22.4% and 47.1%) (P < 0.01). ThePAI-1 4G/4G genotype was significantly associated with endometrial hypoplasia in the infertile patients (OR=4.9, 95% CI: 2.10-10.12).

CONCLUSION

The present findings suggest that the 4G/5G polymorphism of the PAI-1 gene was associated with endometrial hypoplasia in infertile patients.

摘要

目的

探讨纤溶酶原激活物抑制剂(PAI-1)基因多态性与不孕女性子宫内膜发育不全之间的关系。

方法

本研究纳入105例经病理诊断为子宫内膜发育不全且经B超测量子宫内膜厚度的原发性不孕患者,以及85例未孕且生育力正常的对照者。采用聚合酶链反应-限制性片段长度多态性分析检测PAI-1基因-675 4G/5G多态性。

结果

患者组PAI-1基因4G/4G基因型和4G等位基因频率(分别为48.6%和66.2%)高于正常对照组(分别为22.4%和47.1%)(P<0.01)。PAI-1 4G/4G基因型与不孕患者子宫内膜发育不全显著相关(OR=4.9,95%CI:2.10-10.12)。

结论

目前的研究结果表明,PAI-1基因4G/5G多态性与不孕患者子宫内膜发育不全有关。

相似文献

1
[Association of genetic polymorphism in plasminogen activator inhibitor-1 gene with endometrial hypoplasia in infertile women].纤溶酶原激活物抑制剂-1基因多态性与不孕女性子宫内膜发育不全的相关性研究
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):462-4.
2
[Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].纤溶酶原激活物抑制剂-1基因4G/5G多态性与妊娠高血压综合征发病机制的关系
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):173-5.
3
[Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].纤溶酶原激活物抑制剂-1基因和5,10-亚甲基四氢叶酸还原酶基因的遗传多态性与复发性早期自然流产的相关性
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):330-3.
4
Genetic polymorphism in the fibrinolytic system and endometriosis.纤维蛋白溶解系统中的基因多态性与子宫内膜异位症。
Obstet Gynecol. 2006 Jul;108(1):162-8. doi: 10.1097/01.AOG.0000220517.53892.0a.
5
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G多态性与子宫内膜异位症。PAI-1多态性对PAI-1抗原及mRNA表达的影响。
Thromb Res. 2008;122(6):854-60. doi: 10.1016/j.thromres.2008.02.010. Epub 2008 Apr 18.
6
[Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].[广东省汉族2型糖尿病肾病患者纤溶酶原激活物抑制剂-1基因4G/5G多态性与2型糖尿病肾病的关系]
Di Yi Jun Yi Da Xue Xue Bao. 2004 Aug;24(8):904-7.
7
Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.纤溶酶原激活物抑制剂-1启动子基因多态性与心肌梗死的关系
Chin Med J (Engl). 2001 Mar;114(3):266-9.
8
[Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].[纤溶酶原激活物抑制剂-1基因和β纤维蛋白原基因的遗传变异与狼疮性肾炎肾小球微血栓形成及基因剂量效应]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Feb;19(1):1-5.
9
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.乳腺癌患者纤溶酶原激活物抑制剂-1 4G/5G多态性及其与组织纤溶酶原激活物抑制剂-1水平和肿瘤严重程度的关联。
Thromb Res. 2006;117(5):487-92. doi: 10.1016/j.thromres.2005.03.025.
10
[The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].[脑血管疾病中纤溶酶原激活物抑制剂-1启动子区域基因多态性的研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):383-7.

引用本文的文献

1
Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G 多态性与阿尔茨海默病、代谢综合征和女性不孕风险的关联:一项荟萃分析。
Medicine (Baltimore). 2020 Dec 11;99(50):e23660. doi: 10.1097/MD.0000000000023660.